Publications by authors named "Gregg S Nelson"

17Publications

Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma.

Int J Gynecol Pathol 2020 Apr 6. Epub 2020 Apr 6.

Department of Pathology and Laboratory Medicine, McMaster University, Hamilton (M.A.B.) Biostatistics Department, Princess Margaret Cancer Centre (E.G.A.) Division of Biostatistics, Dalla Lana School of Public Health (E.G.A) Department of Pathology and Laboratory Medicine (B.A.C.), University of Toronto Division of Gynecologic Oncology, Princess Margaret Cancer Centre (M.Q.B.), Toronto, Ontario Division of Gynecologic Oncology (N.S., P.G., G.S.N) Department of Pathology and Laboratory Medicine (M.K.), University of Calgary, Alberata, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000674DOI Listing
April 2020

Enhanced recovery after surgery: implementing a new standard of surgical care.

CMAJ 2019 04;191(17):E469-E475

Department of Obstetrics, Gynecology and Reproductive Sciences (Altman), University of Manitoba, Winnipeg, Man.; Division of Gynecologic Oncology (Helpman), McMaster University, Hamilton, Ont.; Division of Gynecologic Oncology (McGee), University of Western Ontario, London, Ont.; Division of Gynecologic Oncology (Auclair, Samouëlian), CHUM, Université de Montréal, Montréal, Que.; Division of Gynecologic Oncology (Brar), University of British Columbia, Vancouver, BC; Department of Gynecologic Oncology (Nelson), Tom Baker Cancer Centre, Calgary, Alta.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.180635DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488471PMC
April 2019

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

Authors:
Peter F Rambau Robert A Vierkant Maria P Intermaggio Linda E Kelemen Marc T Goodman Esther Herpel Paul D Pharoah Stefan Kommoss Mercedes Jimenez-Linan Beth Y Karlan Aleksandra Gentry-Maharaj Usha Menon Susanna Hernando Polo Francisco J Candido Dos Reis Jennifer Anne Doherty Simon A Gayther Raghwa Sharma Melissa C Larson Paul R Harnett Emma Hatfield Jurandyr M de Andrade Gregg S Nelson Helen Steed Joellen M Schildkraut Micheal E Carney Estrid Høgdall Alice S Whittemore Martin Widschwendter Catherine J Kennedy Frances Wang Qin Wang Chen Wang Sebastian M Armasu Frances Daley Penny Coulson Micheal E Jones Micheal S Anglesio Christine Chow Anna de Fazio Montserrat García-Closas Sara Y Brucker Cezary Cybulski Holly R Harris Andreas D Hartkopf Tomasz Huzarski Allan Jensen Jan Lubiński Oleg Oszurek Javier Benitez Fady Mina Annette Staebler Florin Andrei Taran Jana Pasternak Aline Talhouk Mary Anne Rossing Joy Hendley Robert P Edwards Sian Fereday Francesmary Modugno Roberta B Ness Weiva Sieh Mona A El-Bahrawy Stacey J Winham Jenny Lester Susanne K Kjaer Jacek Gronwald Peter Sinn Peter A Fasching Jenny Chang-Claude Kirsten B Moysich David D Bowtell Brenda Y Hernandez Hugh Luk Sabine Behrens Mitul Shah Audrey Jung Prafull Ghatage Jennifer Alsop Kathryn Alsop Jesús García-Donas Pamela J Thompson Anthony J Swerdlow Chloe Karpinskyj Alicia Cazorla-Jiménez María J García Susha Deen Lynne R Wilkens José Palacios Andrew Berchuck Jennifer M Koziak James D Brenton Linda S Cook Ellen L Goode David G Huntsman Susan J Ramus Martin Köbel

J Pathol Clin Res 2018 10 21;4(4):250-261. Epub 2018 Sep 21.

Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174617PMC
October 2018

Letter in response to: McAlpine J, Leon-Castillo A, Bosse T. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses. J Pathol 2018; 244: 538-549.

J Pathol 2018 06 16;245(2):249-250. Epub 2018 Apr 16.

Chair, Gynecologic Oncology Tumour Team, Tom Baker Cancer Centre, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5068DOI Listing
June 2018

The Canadian Gynaecologic Oncology Perioperative Management Survey: Baseline Practice Prior to Implementation of Enhanced Recovery After Surgery (ERAS) Society Guidelines.

J Obstet Gynaecol Can 2016 12 25;38(12):1105-1109.e2. Epub 2016 Oct 25.

Department of Gynecologic Oncology, Tom Baker Cancer Centre, Calgary AB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jogc.2016.09.007DOI Listing
December 2016

Molecular alterations in indolent, aggressive and recurrent ovarian low-grade serous carcinoma.

Histopathology 2017 Feb 7;70(3):347-358. Epub 2016 Nov 7.

Department of Pathology and Laboratory Medicine, Calgary Laboratory Services/Alberta Health Services and University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13071DOI Listing
February 2017

Immunohistochemical Profiling of Endometrial Serous Carcinoma.

Int J Gynecol Pathol 2017 Mar;36(2):128-139

Department of Pathology and Laboratory Medicine (W.C., P.F.R., S.Liu., S.Lee., M.A.D., M.K.), University of Calgary Division of Gynecologic Oncology (G.S.N.), Tom Baker Cancer Centre, Calgary Department of Pathology and Laboratory Medicine (C.H.L.), University of Alberta Division of Pathology and Laboratory Medicine (A.H.), Chinook Regional Hospital, Lethbridge, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000291DOI Listing
March 2017

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.

Gynecol Oncol 2014 Jul 16;134(1):15-9. Epub 2014 May 16.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.05.006DOI Listing
July 2014

PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.

Gynecol Oncol 2014 Jan 19;132(1):188-93. Epub 2013 Nov 19.

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.11.015DOI Listing
January 2014

MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome.

Gynecol Oncol 2013 Nov 11;131(2):309-14. Epub 2013 Aug 11.

Department of Gynecologic Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada; University of Calgary, Calgary, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.08.003DOI Listing
November 2013

The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors.

Mod Pathol 2013 Sep 5;26(9):1255-63. Epub 2013 Apr 5.

Department of Obstetrics and Gynecology, Division of Gynecological Oncology, Winnipeg Health Sciences Center, University of Manitoba, Winnipeg, MB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.55DOI Listing
September 2013

Quantification of ER/PR expression in ovarian low-grade serous carcinoma.

Gynecol Oncol 2013 Feb 24;128(2):371-6. Epub 2012 Oct 24.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.10.013DOI Listing
February 2013

Architectural patterns of ovarian/pelvic high-grade serous carcinoma.

Int J Gynecol Pathol 2012 Sep;31(5):397-404

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0b013e31824c2372DOI Listing
September 2012

Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.

Int J Gynecol Cancer 2012 Jul;22(6):1006-12

Winnipeg Health Sciences Centre & Cancer Care Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31825b7de8DOI Listing
July 2012